Traditional Chinese medicine health product for adjuvant therapy of diabetes

Abstract

The invention discloses a traditional Chinese medicine composition for adjuvant therapy of diabetes, belonging to the field of traditional Chinese medicine health products. The traditional Chinese medicine composition for adjuvant therapy of diabetes comprises the following raw materials in weight to be prepared into active components: 10-50g of astragali radix, 10-50g of radix rehmanniae, 5-30g of atractylodes rhizome, 10-50g of radix scrophulariae, 10-50g of red sage root and 10-50g of kudzu root. The traditional Chinese medicine composition is prepared by the following steps: removing impurities from the crude medicines, putting all the crude medicines into a marmite, adding 1000mm of water, soaking for 1 hour, decocting for 1 hour twice and adding 1000mm of water each time, filtering, combining the filtrates, concentrating the filtrate by pressure reduction to form an extract, and filling into bottles or bags. The liquid medicine also can be dried by vacuum drying and crushed to be used as a raw material to be prepared in various dosage forms such as tablets, capsules, powder and the like. One dose of the traditional Chinese medicine composition is taken in twice per day. The medicament provided by the invention wholly adopts natural Chinese herbal medicines and has a reasonable prescription and obvious curative effects on adjuvant therapy of diabetes without toxic side effects, and the components are simple and easy to obtain and have synergistic actions.

Description

A traditional Chinese medicine health product for auxiliary treatment of diabetes technical field The invention relates to a traditional Chinese medicine health care product, in particular to a traditional Chinese medicine health care product with auxiliary therapeutic effect on diabetes. technical background Diabetes is a systemic chronic metabolic disease that seriously endangers human health. There are more than 300 million diabetic patients in the world. In my country, with the development of the economy, the change of people's diet structure, and the aging of the population, the number of diabetic patients has increased sharply, ranking first in the world. Diabetes has a long course of disease, and it is easy to induce various acute and chronic complications, which poses a huge threat to the physical and mental health of patients. The current routine clinical treatment of diabetes is mainly based on Western medicines, such as biguanides, sulfonylureas, etc. These dru...

AI Technical Summary

Problems solved by technology

The current routine clinical treatment of diabetes is mainly based on Western medicines, such as biguanides, sulfonylureas, etc. These drugs can only lower blood sugar, but cannot effectively repair damaged islet tissue and restore the damaged organs and tissues. More seriously, the body will also cause side effects such as liver and kidney function damage during the process of metabolizing these hypoglycemic drugs, so long-term medication cannot be used